Multiple sclerosis (MS) is an autoimmune disease where T-cells activated against myelin antigens are involved in myelin destruction. Yet, healthy subjects also harbor T-cells responsive to myelin antigens, suggesting that MS patient-derived autoimmune T-cells might bear functional differences from T-cells derived from healthy individuals. We addressed this issue by analyzing gene expression patterns of myelin oligodendrocytic glycoprotein (MOG) responsive T-cell lines generated from MS patients and healthy subjects. We identified 150 transcripts that were differentially expressed between MS patients and healthy controls. The most informative 43 genes exhibited .1.5-fold change in expression level. Eighteen genes were upregulated including BCL2, lifeguard, IGFBP3 and VEGF. Twenty five genes were down-regulated, including apoptotic activators like TNF and heat shock protein genes. This gene expression pattern was unique to MOG specific T-cell lines and was not expressed in T-cell lines reactive to tetanus toxin (TTX). Our results indicate that activation in MS that promotes T-cell survival and expansion, has its own state and that the unique gene expression pattern that characterize autoreactive Tcells in MS represent a constellation of factors in which the chronicity, timing and accumulation of damage make the difference between health and disease.
Introduction
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system and the most common cause of disability in young adults. The etiology of MS involves autoimmune mechanisms within the background of genetic susceptibility (Compston and Sawcer 2002) . Myelin sheath-derived antigenic epitopes involving predominantly myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG) and the proteolipid protein (PLP) are targets for the autoimmune T-cell activation in MS patients. These autoreactive T-cells cause inflammatory reaction leading to myelin damage and axonal loss (Stinissen et al. 1998, Gran and Rostami 2001) . The autoreactive T-cells can be generated and propagated as specific T-cell lines from MS patients and are being used following attenuation to vaccinate MS patients against the disease (Zhang et al. 1993 , Achiron et al. 2004 . The frequency of autoimmune T-cells is influenced by immune regulatory mechanisms involving cytokine stimulation and apoptotic deletion (Pender 1998) . It has been reported that activated T-cell lines responsive to MBP, MOG and other myelin epitopes can be also propagated from peripheral blood mononuclear cells of healthy subjects (Ota et al. 1990 ). This fact led us to examine whether autoreactive T-cell lines derived from MS patients bear functional differences relative to T-cell lines obtained from healthy subjects, in order to evaluate whether these differences bear implications for the pathogenesis and regulation of MS. We applied microarray analysis (Duggan et al. 1999 ) to determine gene expression of MOG stimulated T-cell lines derived from MS patients in comparison to healthy controls. We chose to study T-cells responsive to MOG as this myelin epitope is expressed preferentially on the outermost surface of the myelin sheath, is highly immunogenic and was reported to induce severe experimental autoimmune encephalomyelitis (EAE) in both rodents and primates (Zhong et al. 2000) , as well as to serve a major target for autoimmune T-cells in MS patients (Weissert et al. 2002) .
Materials and methods

Subjects
Four female patients with definite MS and a relapsingremitting course (mean age 38 þ 4.2 years, mean disease duration 9.3 þ 3.3 years) and three age-and sex-matched healthy subjects were included in the study. None of the patients received immunomodulatory drugs or steroid treatment for at least 3 months prior to blood drawn. The study was approved by the institutional review board and the Israel Ministry of Health. Written informed consent was obtained from all participants.
Generation of MOG-reactive T-cell lines
Peripheral blood mononuclear cells (PBMC) were separated on ficoll-hypaque and plated in 96-well Ubottom microplates in the presence of MOG peptide (aa residues 34 -56, 15 mg/ml, Chiron) as previously described (Zhang et al. 1993) . Tetanus toxin (TTX) peptide (aa 176 -195, 15 mg/ml, Hy-labs, Israel) was used as a non-encephalitogenic control antigen. Selection of wells for expansion of lines was performed by 3 H-thymidine incorporation into subdivided primary cultures propagated with the peptide antigens for 7 days and yielding a stimulation index . 3 relative to control cells grown without the peptide. The wells were examined for IFN-g and IL-10 production by RT-PCR. Wells positive for IFN-g and low or negative for IL-10 were selected (Th1 cells). These cells were subcultured on freshly obtained antigen presenting cells (irradiated PBMC) and antigen reactive T-cell lines were generated following expansion with IL-2, 50 U/ml (Boehringer Mannheim, Germany). Cells for analysis from both MS patients and control donors were harvested for experiments 14 -21 days after line selection and expansion over IL-2 at the peak of the logarithmic growth phase. T-cell lines were examined for CD4/CD8 ratio and those with CD4 content . 60% were used for gene microarray analyses.
mRNA preparation
Total RNA was isolated from MOG stimulated T-cell lines (2 £ 10 7 cells) by ice-cold TRIZOL Reagent (Gibco BRL). Poly-A mRNA was isolated with minikit (Oligotex, Qiagen) and used as a template for double stranded cDNA synthesis oligo (dT)-24 primers containing a T7 RNA polymerase promoter site added to the 3 0 -end (Genset). After phenol/ chloroform extraction cDNA was used as a template for in-vitro transcription (Ambion T7 Megascript system) with biotin labeled nucleotides (Enzo Diagnostics). Labeled cRNA was fragmented, quantified by spectrophotometer, and hybridized.
Microarray gene analysis
Each Genechip (U95Av2, 12,000 genes) was hybridized with 10 mg/200 ml hybridization mix, stained and scanned (Hewlett Packard, GeneArray-TM scanner G2500A) according to manufacturer protocol (Affymetrix Inc, Santa Clara, CA). MAS5 software (Affymetrix Inc.) was used to analyze the scanned arrays. All data were normalized by dChip software. Probes that did not have an expression value of 100 in at least one of the arrays were filtered.
Data analysis
The analysis was performed according to the analytical approach as previously described (LovettRacke et al. 1998 , Ben-Dor et al. 2000 , Ria et al. 2001 . Fold ratios were calculated for each gene of the samples against the geometric mean of matched controls. To determine the most informative genes threshold number of misclassifications (TNoM) score was applied (Rechsteiner et al. 2000) . This score counts the number of classification errors that occur between compared groups for each gene of the dataset. The best threshold (TNoM ¼ 0) implies that no errors have been counted and the distinction between the two groups in relation to the expression level of a specific gene is maximal. To select a group of genes with strongly differential expression, we also computed t-test p-value (comparing expression levels of genes from MS patients vs. healthy controls). Genes with TNoM ¼ 0, fold-change . 1.5 (either up or down regulated) and corresponding t-test p value , 0.05, were designated as most informative.
Confirmation of microarray gene expression
Real-Time RT-PCR analysis was preformed for three most informative genes using the QuantiTect SYBER Green PCR kit (QIAGEN) and specific primers for
0 ) was used as a control. Samples were run in triplicates and average fold change calculated.
Results
Gene expression patterns obtained from MOG reactive T-cell lines from MS patients disclosed 150 differentially expressed transcripts with TNoM ¼ 0, as compared to healthy subjects. A pie-chart diagram showing the functional groups of these genes is presented in Figure 1 .
Hierarchical clustering of the 150 differentially expressed genes between MS patients and healthy controls is presented in Figure 2A . We further identified and clustered 43 most informative genes, 18 up-regulated and 25 down-regulated genes ( Figure 2B) .
Analysis of the known biological function of these genes demonstrated an apparently diverse portfolio of activities, Table I . We identified genes coding for proteins involved in the regulation and execution of apoptosis, growth factors, mediators of signal transduction pathways, molecules that participate in inflammation and also genes encoding heat shock proteins, transcription factors and components of different biochemical pathways. More specifically, genes that were up-regulated in the MS patientsderived T-cell lines include growth factors such as vascular endothelial growth factor (VEGF), insulinlike growth factor binding protein 3 (IGF-BP3), CD63 melanoma-1 antigen which is also known to act as a growth regulator. Additionally anti-apoptotic genes such as B-cell CCL/Lymphoma 2 (BCL2) which blocks apoptosis by interfering with activation of caspases, and the lifeguard gene (LFG)-an antiapoptotic component involved in inhibition of induction of apoptosis downstream to the activating signal generated by CD95/Fas receptor interaction with its ligand, and the transcript for MAP activated kinase were recognized. Down-regulated genes included the proteasome activator subunit 2 involved in the presentation of endogenous antigens by MHC class I molecules and required for efficient antigenic epitope processing (Chen et al. 2001) , the 70 kDa heat shock proteins 1A and B (HSP-A1A, HSP-A1B), endothelial cell growth factor 1 (ECGF1), inflammatory cytokines such as small inducible cytokine A4 (SCYA4) which is involved in cell-to-cell signaling, tumor necrosis factor (TNF), interleukin-4 receptor (IL-4R) and nuclear factor of kappa light polypeptide gene enhancer B-cells (NF-KB2) which binds to the kappa-B consensus sequence located in the enhancer region of genes involved in immune response (Zettl et al. 1998) . Real time RT-PCR of three of the most informative genes confirmed the microarray findings with high correlation between methods, Table II . MOG responsive T-cell line gene expression signature was evaluated for specificity by comparison with T-cell lines stimulated by TTX as a nonencephalitogenic antigen. This comparison disclosed that only six of the 150 MOG stimulated differentially expressed genes (CLPTM1, VASP, PDAP1, NFKB2, SLA and BCL2), were common with the expression pattern of TTX stimulated lines.
Discussion
In the present study, we demonstrated that MOG responsive T-cell lines derived from patients with MS have inherent gene transcriptional fingerprint. This transcriptional fingerprint differs from that observed in MOG activated T-cell lines generated in healthy subjects, although both responded to the same myelin antigen. Moreover, this gene expression pattern was found to be unique in MS as it was confined to MOG specific T-cell lines and not to T-cell lines reactive with a non-encephalitogenic TTX antigen. This suggests that the MOG stimulated expression signature in MS is indeed specific and relates to the encephalitogenic antigen.
The differentiating gene transcripts within the signature indicate a functional platform of activities that may be associated with disease pathogenesis. Up-regulated genes include anti-apoptotic genes such as BCL2, LFG and MAP3K12. The BCL2 gene product is an important member of the antiapoptotic proteins. High numbers of BCL2 positive T lymphocytes were found in demyelinating and remyelinating brain lesions from MS patients (Zettl et al. 1998) . Likewise, an increased frequency of MBP-reactive T-cells in MS patients relative to healthy individuals was detected when an antibody to Fas-ligand was used to block apoptosis (Zang et al. 1999) . LFG is known to inhibit T-cell death mediated by the Fas receptor (CD95) through a unique mechanism that down regulates apoptotic signals from Fas (Somia et al. 1999) . Loss of Fas/Fas ligand activities was reported in human autoimmune lymphoproliferative syndrome (Van den Berg et al. 2002) , and in lymphoproliferative lupus-like syndrome in mice (Watanabe et al. 1992) . The MAP3K12 gene is associated with programmed cell death and was reported to catalyze the phosphorylation of BAD, a member of the BCL2 protein family which stimulates BCL2 dependent anti-apoptotic pathways (Yang et al. 1995 , Bonni et al. 1999 . Another aspect of failure to induce apoptosis in the MS-derived T-cell lines is the significant down-regulation of the TNF proapoptotic gene. The inadequate apoptosis present in MS autoreactive T-cell lines could lead to insufficient deletion of autoimmune activated T-cell clones and increase susceptibility to autoimmunity. TNF is also known to stimulate MHC class I presentation in addition to induction of apoptosis. Our finding of down-regulation of MHC class I presentation include the PA28b involved in the presentation of endogenous antigens and required for efficient antigenic epitope processing. Accordingly, we suggest that a weaker antigenic MHC class I presenting capability might distinguish MS-patient derived T-cell lines from their healthy counterparts. It is conceivable that a lower expression of MHC class-I on CD4 autoimmune T-cells might enable them to escape regulation by CD8 cells that recognize autoimmune idiotypes (Zang et al. 2000) . We also found higher expression of IGFBP3 and VEGF in MOG responsive T-cell lines derived from MS patients. IGFBP3 has previously been reported to be expressed on human stimulated and unstimulated lymphocytes (Kooijman et al. 1995) . In murine EAE, IGF-1/IGFBP3 treatment resulted in more severe disease (Lock et al. 2002 ) that reported increased expression of IGFBP3 in acute brain lesions of MS patients compared to silent MS lesions. In addition to increased survival potential, our findings suggest that autoreactive T-cells in MS also have an expansion advantage compared with T-cells from healthy individuals. Furthermore, migration of autoimmune T-cells into the brain would be expected to be assisted by over-expression of VEGF. VEGF enhances vascular permeability and may facilitate migration of lymphocytes into the brain and induction of autoreactive inflammatory response. Taken together the combined effects of down-regulation of apoptosis associated genes, up regulation of antiapoptotic genes, increased expansion capability of autoreactive T-cells and enhanced ability to penetrate the brain may lead to perpetuated pathologic cellular proliferation and tissue destruction within the central nervous system, along with increased resistance to regulation. These specific gene transcripts can define some of the requirements for an individual to develop MS. It is of noteworthy that despite activation in-vitro with the same MOG epitope, MOG reactive T-cell lines from healthy subjects did not attain the gene expression profile that characterized the MS patient-derived cells. Thus, these findings support the concept that not all autoimmune T-cells are equal; autoimmune T-cells from MS patients follow a unique pattern of T-cell activation that appears to be more resilient to apoptosis and can support long term survival. Although, T-cell lines derived from MS patients and healthy donors responded to the same autoantigen, the gene expression imprints that are unique to each group were preserved. The nature of the stimuli that generate aberrant autoimmune T-cell gene expression has yet to be identified in order to determine whether their formation is merely the result of the chronic immune stimulation driven by other factors in MS, or whether such T-cells function are the primary drivers of the pathogenic MS process (Ria et al. 2001) . On the other hand, the difference we demonstrated between autoreactive T-cells in patients and healthy subjects suggests that though both are activated and against the same myelin antigen their state is different, and the change in state is of importance. This transformation between autoimmune reactivity and autoimmune disease and the characterization of such driver autoreactive T-cells dictating the state of immunity -autoimmunity, may contribute to understanding autoimmune diseases and possibly contribute to the designation of effective treatments in MS.
